Historical record - last NADAC effective date: 9/17/2014
Product Information
NIZATIDINE 300 MG CAPSULE is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $0.5821 per EA under NDC 55111031130. Its NADAC has been published 29 times since Mar 12, 2014.
FDA first approved this application on Sep 15, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the Nizatidine market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
300 mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
55111031130
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/17/2014
Active Ingredients
NIZATIDINEApproval Type
Generic (ANDA)
FDA Application
ANDA077314FDA Approved
9/15/2005
TE Code
AB
On Market Since
9/15/2005
Pharmacological Classes
Price Statistics
The NADAC for NIZATIDINE 300 MG CAPSULE has been published 29 times since Mar 12, 2014, and over the history we have for it it has declined 7.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5821 per EA |
|---|---|
| All-time high | $0.7062 (Apr 16, 2014) |
| All-time low | $0.5454 (May 21, 2014) |
| Median price | $0.6273 |
| Average price | $0.6173 |
| Largest weekly change | -22.2% (Apr 23, 2014) |
| Weeks tracked | 29 |
| Tracking since | Mar 12, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-7.2%
Last surveyed Sep 24, 2014 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NIZATIDINE 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for NIZATIDINE 300 MG CAPSULE, manufactured by Dr. Reddy's Laboratories Inc., is $0.5821 per EA (NDC 55111031130), effective Sep 24, 2014.
How has the price of NIZATIDINE 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for NIZATIDINE 300 MG CAPSULE has declined 7.2%. It has been tracked across 29 weekly CMS publications since Mar 12, 2014.
What are the highest and lowest recorded NADAC prices for NIZATIDINE 300 MG CAPSULE?
Since Mar 12, 2014, the NADAC for NIZATIDINE 300 MG CAPSULE has ranged from a low of $0.5454 (May 21, 2014) to a high of $0.7062 (Apr 16, 2014), with a median of $0.6273 per EA.
Are there cheaper alternatives to NIZATIDINE 300 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as NIZATIDINE 300 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures NIZATIDINE 300 MG CAPSULE?
NIZATIDINE 300 MG CAPSULE (NDC 55111031130) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.